MELISSA BEAN-TANNER: Open Payments
NPI 1083310452 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 7 payments from 6 companies in 2025. Trend: 2023 $718 · 2024 $943 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $121 |
| ABBVIE INC. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Ardelyx, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: Trodelvy, RINVOQ, DUPIXENT, Enhertu, IBSRELA, ENTYVIO.
Industry payments across LA — which companies pay providers there.
